Europe Drug Discovery Informatics Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Drug discovery is the process through which new medicines are identified. In the past, most of the drugs have been discovered by identifying the active ingredient from the traditional remedies. Improvements to traditional computational drug applications will continue to provide the incremental benefits. Drug discovery informatics is an extremely complex process that involves generation of larger volumes of data. At present, the market for drug discovery informatics is largely unmet.

Europe Drug Discovery Informatics Market Size & Growth:

The Europe drug discovery informatics Market size is projected to reach approximately $ XX m by the end of 2024 with a CAGR close to X% from $XX m in 2018 during the forecast timeline 2018-2024. The Key factors that drive the growth of the market include the rising R&D expenditure, the increasing focus on drug discovery, need to control the drug discovery and the development costs, high throughput screening methods and So On. The development decisions for the drug should be taken in the earlier stages by the skilled professionals to get the expected drug.

Europe Drug Discovery Informatics Market Share:

Various parameters divided the Europe drug discovery informatics market. By the Solution, they are divided into Software and services. Among them, software plays an important role not only in drug discovery but also in drug development. Nowadays software companies are investing a lot of money for drug discovery. By the End-User, they are divided into Pharmaceutical & Biotechnology and Contract research organisations. Among them, Contract research organisations will play a significant role because the contract research organisations will provide support to the pharmaceuticals, biotechnology and medical devices in the form of research services. By the Function, they are divided into docking, molecular modelling, target data analysis and others. Among them, molecular modelling plays a vital role because Docking is a method in molecular modelling which predicts the preferred orientation of one molecule. By Geography, Germany has the most significant market share regarding drug discovery due to the presence of well-established pharmaceuticals in that region.

Europe Drug Discovery Informatics Market Trends:

• Dassault Systemes and Ipsen Sign collaborative agreement to develop innovative programs to support Ipsen’s drug discovery.
• Infosys partnered with a global pharmaceutical company to compress the discovery cycle by helping scientists analyse data, collaborative and make informed decisions regarding compounds.
• Clarivate analytics launches new product suite which will reduce the amount of time and risk for researchers in reaching their targets.

Europe Drug Discovery Informatics Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
• Infosys
• Collaborative Drug Discovery
• Dassault Systemes
• Certara Pharma